These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14478187)

  • 1. [Endocrinological study of prostatic carcinoma: effects of anti-androgenic treatments on urinary 17-ketosteroid and its fractionation].
    NAKANO K
    Nihon Hinyokika Gakkai Zasshi; 1961 Dec; 52():1047-77. PubMed ID: 14478187
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endocrinological study on prostatic carcinoma: anti-androgenic therapy and extragonadal androgens (analysis of 17-ketosteroid fractions by gas-liquid chromatography].
    Ishibashi H
    Nihon Hinyokika Gakkai Zasshi; 1968 May; 59(5):351-73. PubMed ID: 4302504
    [No Abstract]   [Full Text] [Related]  

  • 3. [Endocrinological enviroment in patients with uterine myoma with special reference to urinary neutral 17-ketosteroid excretion value in urine].
    Sasaki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1966 May; 18(5):451-9. PubMed ID: 6006853
    [No Abstract]   [Full Text] [Related]  

  • 4. [DETERMINATION OF URINARY 17-KETOSTEROID LEVELS IN THE DIAGNOSIS OF PROSTATE CARCINOMA].
    HAHN M; PAVLIK F
    Cas Lek Cesk; 1963 Jul; 102():772-5. PubMed ID: 14068693
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study on the fractionation of urinary 17-ketosteroids in the field of urology. II. The fractionation of urinary 17-ketosteroids in the patients of prostatic cancer].
    MORIMOTO J
    Nihon Hinyokika Gakkai Zasshi; 1962 Jul; 53():516-30. PubMed ID: 14476073
    [No Abstract]   [Full Text] [Related]  

  • 6. The conversion of cortisone to 17-ketosteroids in patients with carcinoma of the prostate and of the lung.
    SLAUNWHITE WR; LIST B; SOKAL JE
    J Lab Clin Med; 1959 May; 53(5):737-42. PubMed ID: 13654915
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sex hormones in cases of carcinoma of the uterus; urinary elimination of estrogen catabolytes of pregnandiol and 17-ketosteroids].
    BALASSI GP; RICCA C
    Minerva Ginecol; 1951; 3(6):269-77. PubMed ID: 14863150
    [No Abstract]   [Full Text] [Related]  

  • 8. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
    Platz EA; Giovannucci E
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cortisone and cortisol on 17-ketosteroid excretion in carcinoma of the prostate and other neoplasms.
    SOKAL JE; BUCHWALD KW
    Cancer; 1959; 12(1):183-6. PubMed ID: 13618868
    [No Abstract]   [Full Text] [Related]  

  • 10. [EFFECT OF ADMINISTRATION OF DEHYDROEPIANDROSTERONE ALONE OR COMBINED WITH SEX HORMONES ON THE 17-KETOSTEROID LEVELS IN FEMALE URINE (BY THE SOLVOLYSIS METHOD)].
    MATSUDA H
    Nihon Sanka Fujinka Gakkai Zasshi; 1963 Oct; 15():1130-6. PubMed ID: 14092836
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relation between vitamin E and the male sex hormone; 17-ketosteroid excretion after oral administration of alpha-tocopherol acetate in the healthy male].
    HUPPE J; MELLINGHOFF K
    Z Gesamte Exp Med; 1952 May; 118(4):346-51. PubMed ID: 14951452
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of steroid preparations on chromatographic fractionation of 17-ketosteroids in patients with prostatic carcinoma].
    Frugoni A; Chianta A
    Minerva Urol; 1968; 20(4):157-60. PubMed ID: 5752881
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinatal sex hormones and risk of breast and prostate cancers in adulthood.
    Shibata A; Minn AY
    Epidemiol Rev; 2000; 22(2):239-48. PubMed ID: 11218375
    [No Abstract]   [Full Text] [Related]  

  • 16. Sex hormone therapy in the treatment of carcinoma of the prostate and benign prostatic hypertrophy.
    HECKEL NJ
    Clinics; 1946 Dec; 5(4):860-77. PubMed ID: 20283908
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of norethandrolone on 17-ketosteroid excretion in prostatic cancer patients.
    BRENDLER H; WINKLER BS
    J Clin Endocrinol Metab; 1959 Feb; 19(2):183-92. PubMed ID: 13620743
    [No Abstract]   [Full Text] [Related]  

  • 18. An evaluation of sex hormones in the treatment of carcinoma of the prostate gland.
    HECKEL NJ
    Miss Valley Med J; 1947 Jul; 69(3):102-4. PubMed ID: 20241252
    [No Abstract]   [Full Text] [Related]  

  • 19. The importance of stromal tissue in benign prostatic hyperplasia: morphological, immunofluorescence and endocrinological investigations.
    Bartsch G; Brüngger A; Schweikert U; Hintner H; Stanzl U; Marth C; Daxenbichler G; Rohr HP
    Prog Clin Biol Res; 1984; 145():159-79. PubMed ID: 6201873
    [No Abstract]   [Full Text] [Related]  

  • 20. [STEROID HORMONE EXCRETION OF PATIENTS WITH DISEASES OF THE PROSTATE UNDER TREATMENT WITH NATURAL AND SYNTHETIC ESTROGENS].
    ZIMMERMANN W; BUESCHER HK; TAUPITZ A; THEWALT K
    Acta Endocrinol (Copenh); 1964; 45():SUPPL90:211-25. PubMed ID: 14111328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.